[PCRX] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -322.97%
YoY- -851.09%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 167,466 127,722 117,484 104,685 83,448 67,335 68,355 16.09%
PBT 2,069 24,231 6,150 -5,816 -702 -7,552 -22,128 -
Tax 2,762 6,571 -123,969 271 -62 45 36 106.06%
NP -693 17,660 130,119 -6,087 -640 -7,597 -22,164 -43.85%
Tax Rate -133.49% -27.12% 2,015.76% - - - - -
Total Cost 168,159 110,062 -12,635 110,772 84,088 74,932 90,519 10.86%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -0.41 13.83 110.75 -5.81 -0.77 -11.28 -32.42 -51.71%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.02 0.40 3.03 -0.15 -0.02 -0.19 -0.59 -43.09%
EPS Diluted -0.02 0.39 2.94 -0.15 -0.02 -0.19 -0.59 -43.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.